Is Miller-Dieker syndrome hereditary?

Miller-Dieker syndrome is a genetic condition caused by a deletion of genetic material on chromosome 17, but it is rarely inherited from parents. In the vast majority of cases, Miller-Dieker syndrome occurs as a de novo (spontaneous) event in the developing embryo, meaning neither parent carries the deletion.

Is Miller-Dieker syndrome considered a hereditary condition?

While Miller-Dieker syndrome is a genetic disorder, it is not typically "hereditary" in the sense that it is passed down from a parent to a child. The condition is caused by a microdeletion of a specific region on the short arm of chromosome 17 (specifically 17p13.3). Because this deletion disrupts multiple genes, including the PAFAH1B1 (also known as LIS1) gene, it leads to the characteristic brain malformations known as lissencephaly. In about 80% of cases, this deletion occurs de novo, meaning it happens spontaneously during the formation of reproductive cells or in early embryonic development.

What is the risk of recurrence for parents of a child with Miller-Dieker syndrome?

For most families, the risk of having another child with Miller-Dieker syndrome is very low, typically less than 1%. However, in a small percentage of cases, one parent may carry a balanced chromosome rearrangement (such as a balanced translocation) involving chromosome 17. If a parent carries such a rearrangement, the risk of recurrence can be significantly higher. Because of this, it is essential for both parents to undergo chromosomal analysis (karyotyping or chromosomal microarray) to determine if the deletion was a sporadic event or inherited from a parent with a balanced translocation.

How is Miller-Dieker syndrome diagnosed through genetic testing?

The diagnosis of Miller-Dieker syndrome is confirmed through specialized genetic testing that identifies the loss of genetic material on chromosome 17. The following methods are commonly used by clinicians:

• Chromosomal Microarray (CMA): This is the current gold-standard test used to detect small deletions or duplications of genetic material that are too small to be seen on a traditional karyotype.


• Fluorescence In Situ Hybridization (FISH): This targeted test can confirm the presence of the 17p13.3 deletion.


• Karyotyping: This is used to evaluate the overall structure of chromosomes to rule out a balanced translocation in the parents.

What is the role of genetic counseling for affected families?

Genetic counseling is a vital step for families impacted by Miller-Dieker syndrome. A genetic counselor can help explain the complex results of chromosomal testing, interpret the recurrence risk based on parental testing, and discuss reproductive options. For those planning future pregnancies, genetic counselors can provide information on prenatal diagnostic procedures, such as amniocentesis or chorionic villus sampling (CVS), which can detect the 17p13.3 deletion in a developing fetus. At DiseaseMaps.org, we have seen 19 community members connect over their experiences with Miller-Dieker syndrome, highlighting the importance of peer support alongside clinical guidance.

Next steps

• Consult with a board-certified clinical geneticist to undergo parental chromosome testing.


• Request a referral to a genetic counselor to discuss family planning and recurrence risks.


• Connect with the 19 other community members on DiseaseMaps.org to share resources and support.


• Review information from the NIH Genetic and Rare Diseases (GARD) Information Center for the latest clinical updates on Miller-Dieker syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• National Institutes of Health (NIH) GARD: Miller-Dieker syndrome overview.


• Orphanet: Rare disease database entry for Miller-Dieker syndrome (ORPHA:588).


• OMIM (Online Mendelian Inheritance in Man): Miller-Dieker syndrome (Entry #247200).


• National Organization for Rare Disorders (NORD): Patient resources for lissencephaly and Miller-Dieker syndrome.